Acquired, but not innate, immune responses to Streptococcus pneumoniae are compromised by neutralization of CD40L
Acquired, but not innate, immune responses to Streptococcus pneumoniae are compromised by neutralization of CD40L
复制标题
DOI:
10.1128/iai.68.2.511-517.2000
复制
发表时间:
2000-02-01
影响因子:
3.1
通讯作者:
Purkerson, JM
中科院分区:
文献类型:
--
作者:
Hwang, YI;Nahm, MH;Purkerson, JM
Streptococcus pneumoniae is a significant pathogen of young children and the elderly. Systemic infection by pneumococci is a complex process involving several bacterial and host factors. We have investigated the role of CD40L in host defense against pneumococcal infection. Treatment of mice with MR-I antibody (anti-CD154/CD40L) markedly reduced antibody responses to the pneumococcal protein PspA, elicited by immunization of purified protein or whole bacteria. In mice immunized with whole bacteria, MR-1 treatment reduced antibody responses to capsular polysaccharides but not cell wall polysaccharides. MR-1 did not suppress antibody responses to isolated capsular polysaccharides but did reduce the production of antibody to a capsular polysaccharide-protein conjugate, indicating that when presented in the context of whole bacteria, the humoral response to capsular polysaccharides is partially T-cell dependent. Despite the reduction of the protective humoral responses to pneumococcal infection, administration of MR-1 had no effect on sepsis, lung infection, or nasal carriage in nonimmune mice inoculated with virulent pneumococci. Thus, short-term neutralization of CD40L does not compromise innate host defenses against pneumococcal invasion.